Host responses to live-attenuated Venezuelan equine encephalitis virus (TC-83)

References

• Ryman KD, Klimstra WB. Host responses to alphavirus infection. Immunol Rev 2008; 225:27 - 45; http://dx.doi.org/10.1111/j.1600-065X.2008.00670.x; PMID: 18837774
   PubMed Web of Science ®Google Scholar
• Weaver SC, Reisen WK. Present and future arboviral threats. Antiviral Res 2010; 85:328 - 45; http://dx.doi.org/10.1016/j.antiviral.2009.10.008; PMID: 19857523
   PubMed Web of Science ®Google Scholar
• Weaver SC, Ferro C, Barrera R, Boshell J, Navarro JC. Venezuelan equine encephalitis. Annu Rev Entomol 2004; 49:141 - 74; http://dx.doi.org/10.1146/annurev.ento.49.061802.123422; PMID: 14651460
   PubMed Web of Science ®Google Scholar
• Weaver SC, Salas R, Rico-Hesse R, Ludwig GV, Oberste MS, Boshell J, et al, VEE Study Group. Re-emergence of epidemic Venezuelan equine encephalomyelitis in South America. Lancet 1996; 348:436 - 40; http://dx.doi.org/10.1016/S0140-6736(96)02275-1; PMID: 8709783
   PubMed Web of Science ®Google Scholar
• Zacks MA, Paessler S. Encephalitic alphaviruses. Vet Microbiol 2010; 140:281 - 6; http://dx.doi.org/10.1016/j.vetmic.2009.08.023; PMID: 19775836
   PubMed Web of Science ®Google Scholar
• Berge TO, Banks IS, Tigertt WD. Attenuation of Venezuelan equine encephalomyelitis virus by in vitro cultivation in guinea pig heart cells. Am J Epidemiol 1961; 73:209 - 18
   Web of Science ®Google Scholar
• Pittman PR, Makuch RS, Mangiafico JA, Cannon TL, Gibbs PH, Peters CJ. Long-term duration of detectable neutralizing antibodies after administration of live-attenuated VEE vaccine and following booster vaccination with inactivated VEE vaccine. Vaccine 1996; 14:337 - 43; http://dx.doi.org/10.1016/0264-410X(95)00168-Z; PMID: 8744562
   PubMed Web of Science ®Google Scholar
• Pittman PR, Liu C-T, Cannon TL, Mangiafico JA, Gibbs PH. Immune interference after sequential alphavirus vaccine vaccinations. Vaccine 2009; 27:4879 - 82; http://dx.doi.org/10.1016/j.vaccine.2009.02.090; PMID: 19576665
   PubMed Web of Science ®Google Scholar
• McClain DJ, Pittman PR, Ramsburg HH, Nelson GO, Rossi CA, Mangiafico JA, et al. Immunologic interference from sequential administration of live attenuated alphavirus vaccines. J Infect Dis 1998; 177:634 - 41; http://dx.doi.org/10.1086/514240; PMID: 9498442
   PubMed Web of Science ®Google Scholar
• Grieder FB, Vogel SN. Role of interferon and interferon regulatory factors in early protection against Venezuelan equine encephalitis virus infection. Virology 1999; 257:106 - 18; http://dx.doi.org/10.1006/viro.1999.9662; PMID: 10208925
   PubMed Web of Science ®Google Scholar
• Sharma A, Maheshwari RK. Oligonucleotide array analysis of Toll-like receptors and associated signalling genes in Venezuelan equine encephalitis virus-infected mouse brain. J Gen Virol 2009; 90:1836 - 47; http://dx.doi.org/10.1099/vir.0.010280-0; PMID: 19369408
   PubMed Web of Science ®Google Scholar
• Sharma A, Bhomia M, Honnold SP, Maheshwari RK. Role of adhesion molecules and inflammation in Venezuelan equine encephalitis virus infected mouse brain. Virol J 2011; 8:197; http://dx.doi.org/10.1186/1743-422X-8-197; PMID: 21529366
   PubMed Web of Science ®Google Scholar
• Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc, B 1995; 57:289 - 300
   Google Scholar
• Weaver SC, Barrett AD. Transmission cycles, host range, evolution and emergence of arboviral disease. Nat Rev Microbiol 2004; 2:789 - 801; http://dx.doi.org/10.1038/nrmicro1006; PMID: 15378043
   PubMed Web of Science ®Google Scholar
• Gubler DJ. The global emergence/resurgence of arboviral diseases as public health problems. Arch Med Res 2002; 33:330 - 42; http://dx.doi.org/10.1016/S0188-4409(02)00378-8; PMID: 12234522
   PubMed Web of Science ®Google Scholar
• Reichert E, Clase A, Bacetty A, Larsen J. Alphavirus antiviral drug development: scientific gap analysis and prospective research areas. Biosecur Bioterror 2009; 7:413 - 27; http://dx.doi.org/10.1089/bsp.2009.0032; PMID: 20028250
   PubMed Web of Science ®Google Scholar
• Schoneboom BA, Lee JS, Grieder FB. Early expression of IFN-alpha/beta and iNOS in the brains of Venezuelan equine encephalitis virus-infected mice. J Interferon Cytokine Res 2000; 20:205 - 15; http://dx.doi.org/10.1089/107999000312621; PMID: 10714557
   PubMed Web of Science ®Google Scholar
• Gardner CL, Burke CW, Tesfay MZ, Glass PJ, Klimstra WB, Ryman KD. Eastern and Venezuelan equine encephalitis viruses differ in their ability to infect dendritic cells and macrophages: impact of altered cell tropism on pathogenesis. J Virol 2008; 82:10634 - 46; http://dx.doi.org/10.1128/JVI.01323-08; PMID: 18768986
   PubMed Web of Science ®Google Scholar
• Koterski J, Twenhafel N, Porter A, Reed DS, Martino-Catt S, Sobral B, et al. Gene expression profiling of nonhuman primates exposed to aerosolized Venezuelan equine encephalitis virus. FEMS Immunol Med Microbiol 2007; 51:462 - 72; http://dx.doi.org/10.1111/j.1574-695X.2007.00319.x; PMID: 17894805
   PubMed Web of Science ®Google Scholar
• Hammamieh R, Barmada M, Ludwig G, Peel S, Koterski N, Jett M. Blood genomic profiles of exposures to Venezuelan equine encephalitis in Cynomolgus macaques (Macaca fascicularis). Virol J 2007; 4:82; http://dx.doi.org/10.1186/1743-422X-4-82; PMID: 17727720
   PubMed Web of Science ®Google Scholar
• Bhomia M, Balakathiresan N, Sharma A, Gupta P, Biswas R, Maheshwari R. Analysis of microRNAs induced by Venezuelan equine encephalitis virus infection in mouse brain. Biochem Biophys Res Commun 2010; 395:11 - 6; http://dx.doi.org/10.1016/j.bbrc.2010.03.091; PMID: 20303929
   PubMed Web of Science ®Google Scholar
• Grieder FB, Davis BK, Zhou XD, Chen SJ, Finkelman FD, Gause WC. Kinetics of cytokine expression and regulation of host protection following infection with molecularly cloned Venezuelan equine encephalitis virus. Virology 1997; 233:302 - 12; http://dx.doi.org/10.1006/viro.1997.8617; PMID: 9217054
   PubMed Web of Science ®Google Scholar
• Marié I, Durbin JE, Levy DE. Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7. EMBO J 1998; 17:6660 - 9; http://dx.doi.org/10.1093/emboj/17.22.6660; PMID: 9822609
   PubMed Web of Science ®Google Scholar
• Velu V, Saravanan S, Nandakumar S, Shankar EM, Vengatesan A, Jadhav SS, et al. Relationship between T-lymphocyte cytokine levels and sero-response to hepatitis B vaccines. World J Gastroenterol 2008; 14:3534 - 40; http://dx.doi.org/10.3748/wjg.14.3534; PMID: 18567083
   PubMed Web of Science ®Google Scholar
• Lukaszewski RA, Brooks TJ. Pegylated alpha interferon is an effective treatment for virulent venezuelan equine encephalitis virus and has profound effects on the host immune response to infection. J Virol 2000; 74:5006 - 15; http://dx.doi.org/10.1128/JVI.74.11.5006-5015.2000; PMID: 10799574
   PubMed Web of Science ®Google Scholar
• Malaspina A, Moir S, DiPoto AC, Ho J, Wang W, Roby G, et al. CpG oligonucleotides enhance proliferative and effector responses of B Cells in HIV-infected individuals. J Immunol 2008; 181:1199 - 206; PMID: 18606673
   PubMed Web of Science ®Google Scholar
• Tissari J, Sirén J, Meri S, Julkunen I, Matikainen S. IFN-alpha enhances TLR3-mediated antiviral cytokine expression in human endothelial and epithelial cells by up-regulating TLR3 expression. J Immunol 2005; 174:4289 - 94; PMID: 15778392
   PubMed Web of Science ®Google Scholar
• Liston P, Fong WG, Kelly NL, Toji S, Miyazaki T, Conte D, et al. Identification of XAF1 as an antagonist of XIAP anti-Caspase activity. Nat Cell Biol 2001; 3:128 - 33; http://dx.doi.org/10.1038/35055027; PMID: 11175744
   PubMed Web of Science ®Google Scholar
• Ekchariyawat P, Thitithanyanont A, Sirisinha S, Utaisincharoen P. Apoptosis induced by avian H5N1 virus in human monocyte-derived macrophages involves TRAIL-inducing caspase-10 activation. Innate Immun 2011; In press http://dx.doi.org/10.1177/1753425911410998; PMID: 21911414
   PubMed Web of Science ®Google Scholar
• King RG, Herrin BR, Justement LB. Differential expression of the adaptor protein HSH2 controls the quantitative and qualitative nature of the humoral response. J Immunol 2011; 187:3565 - 77; http://dx.doi.org/10.4049/jimmunol.1101534; PMID: 21873522
   PubMed Web of Science ®Google Scholar
• Perchonock CE, Fernando MC, Quinn WJ 3rd, Nguyen CT, Sun J, Shapiro MJ, et al. Negative regulation of interleukin-2 and p38 mitogen-activated protein kinase during T-cell activation by the adaptor ALX. Mol Cell Biol 2006; 26:6005 - 15; http://dx.doi.org/10.1128/MCB.02067-05; PMID: 16880512
   PubMed Web of Science ®Google Scholar
• Herrin BR, Justement LB. Expression of the adaptor protein hematopoietic Src homology 2 is up-regulated in response to stimuli that promote survival and differentiation of B cells. J Immunol 2006; 176:4163 - 72; PMID: 16547253
   PubMed Web of Science ®Google Scholar
• Holness CL, Simmons DL. Molecular cloning of CD68, a human macrophage marker related to lysosomal glycoproteins. Blood 1993; 81:1607 - 13; PMID: 7680921
   PubMed Web of Science ®Google Scholar
• Sabbah A, Chang TH, Harnack R, Frohlich V, Tominaga K, Dube PH, et al. Activation of innate immune antiviral responses by Nod2. Nat Immunol 2009; 10:1073 - 80; http://dx.doi.org/10.1038/ni.1782; PMID: 19701189
   PubMed Web of Science ®Google Scholar
• Yamamoto T, Yamanashi Y, Toyoshima K. Association of Src-family kinase Lyn with B-cell antigen receptor. Immunol Rev 1993; 132:187 - 206; http://dx.doi.org/10.1111/j.1600-065X.1993.tb00843.x; PMID: 8349296
   PubMed Web of Science ®Google Scholar
• Okada Y, Matsuura E, Tozuka Z, Nagai R, Watanabe A, Matsumoto K, et al. Upstream stimulatory factors stimulate transcription through E-box motifs in the PF4 gene in megakaryocytes. Blood 2004; 104:2027 - 34; http://dx.doi.org/10.1182/blood-2003-09-3107; PMID: 15187018
   PubMed Web of Science ®Google Scholar
• Le Bouteiller P, Tabiasco J, Polgar B, Kozma N, Giustiniani J, Siewiera J, et al. CD160: a unique activating NK cell receptor. Immunol Lett 2011; 138:93 - 6; http://dx.doi.org/10.1016/j.imlet.2011.02.003; PMID: 21324341
   PubMed Web of Science ®Google Scholar
• Harcourt G, Hellier S, Bunce M, Satsangi J, Collier J, Chapman R, et al. Effect of HLA class II genotype on T helper lymphocyte responses and viral control in hepatitis C virus infection. J Viral Hepat 2001; 8:174 - 9; http://dx.doi.org/10.1046/j.1365-2893.2001.00289.x; PMID: 11380794
   PubMed Web of Science ®Google Scholar
• Fallas JL, Tobin HM, Lou O, Guo D, Sant’Angelo DB, Denzin LK. Ectopic expression of HLA-DO in mouse dendritic cells diminishes MHC class II antigen presentation. J Immunol 2004; 173:1549 - 60; PMID: 15265882
   PubMed Web of Science ®Google Scholar
• Lafon M, Prehaud C, Megret F, Lafage M, Mouillot G, Roa M, et al. Modulation of HLA-G expression in human neural cells after neurotropic viral infections. J Virol 2005; 79:15226 - 37; http://dx.doi.org/10.1128/JVI.79.24.15226-15237.2005; PMID: 16306594
   PubMed Web of Science ®Google Scholar
• Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003; 4:249 - 64; http://dx.doi.org/10.1093/biostatistics/4.2.249; PMID: 12925520
   PubMed Web of Science ®Google Scholar